Salem Investment Counselors’s Lexicon Pharmaceuticals LXRX Stock Holding History

Salem Investment Counselors’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-73,000	Closed	-$136K	–	1084
2022 Q2	$136K	Hold	73,000	–	–	0.01%	380
2022 Q1	$153K	Hold	73,000	–	–	0.01%	372
2021 Q4	$288K	Hold	73,000	–	–	0.01%	329
2021 Q3	$351K	Hold	73,000	–	–	0.02%	283
2021 Q2	$335K	Hold	73,000	–	–	0.02%	278
2021 Q1	$429K	Hold	73,000	–	–	0.03%	221
2020 Q4	$250K	Buy	+73,000	New	+$139K	0.02%	257

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return

Salem Investment Counselors's LXRX Position: Q3 2022 in Review

Salem Investment Counselors sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2022, closing a stake of 73,000 shares — an estimated $136K sold.

Salem Investment Counselors first reported a position in LXRX in Q4 2020 and held it in 7 quarters. The position peaked at $429K in Q1 2021. 98 funds tracked by Wall St. Rank hold LXRX as of Q3 2022.

Salem Investment Counselors reported no remaining Lexicon Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Salem Investment Counselors sold 73,000 Lexicon Pharmaceuticals shares in Q3 2022, an estimated $136K.
Salem Investment Counselors first reported a position in Lexicon Pharmaceuticals in Q4 2020 and held it in 7 quarters.
Salem Investment Counselors's Lexicon Pharmaceuticals position peaked at $429K in Q1 2021.
98 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2022.

Based on Salem Investment Counselors's 13F filing for Q3 2022, filed 9 Nov 2022.